These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11343612)

  • 21. Investigating the role of the brain-derived neurotrophic factor (BDNF) val66met variant in obsessive-compulsive disorder (OCD).
    Hemmings SM; Kinnear CJ; Van der Merwe L; Lochner C; Corfield VA; Moolman-Smook JC; Stein DJ
    World J Biol Psychiatry; 2008; 9(2):126-34. PubMed ID: 17853300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular genetics of obsessive-compulsive disorder: a comprehensive meta-analysis of genetic association studies.
    Taylor S
    Mol Psychiatry; 2013 Jul; 18(7):799-805. PubMed ID: 22665263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin transporter gene polymorphism implicates reduced orbito-frontal cortex in obsessive-compulsive disorder.
    Atmaca M; Onalan E; Yildirim H; Yuce H; Koc M; Korkmaz S; Mermi O
    J Anxiety Disord; 2011 Jun; 25(5):680-5. PubMed ID: 21441009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alcohol Dependence and Genetic Variability in the Serotonin Pathway among Currently and Formerly Alcohol-Dependent Males.
    Plemenitas A; Kastelic M; o Porcelli S; Serretti A; Dolžan V; Kores Plesnicar B
    Neuropsychobiology; 2015; 72(1):57-64. PubMed ID: 26352193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pilot study exploring the association of morphological changes with 5-HTTLPR polymorphism in OCD patients.
    Honda S; Nakao T; Mitsuyasu H; Okada K; Gotoh L; Tomita M; Sanematsu H; Murayama K; Ikari K; Kuwano M; Yoshiura T; Kawasaki H; Kanba S
    Ann Gen Psychiatry; 2017; 16():2. PubMed ID: 28203264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New evidence for the association of the serotonin transporter gene (SLC6A4) haplotypes, threatening life events, and depressive phenotype.
    Lazary J; Lazary A; Gonda X; Benko A; Molnar E; Juhasz G; Bagdy G
    Biol Psychiatry; 2008 Sep; 64(6):498-504. PubMed ID: 18486105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophrenia.
    Fan JB; Sklar P
    Mol Psychiatry; 2005 Oct; 10(10):928-38, 891. PubMed ID: 15940296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obsessive-compulsive disorder, factor-analyzed symptom dimensions and serotonin transporter polymorphism.
    Kim SJ; Lee HS; Kim CH
    Neuropsychobiology; 2005; 52(4):176-82. PubMed ID: 16220023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early- versus late-onset obsessive-compulsive disorder: investigating genetic and clinical correlates.
    Hemmings SM; Kinnear CJ; Lochner C; Niehaus DJ; Knowles JA; Moolman-Smook JC; Corfield VA; Stein DJ
    Psychiatry Res; 2004 Sep; 128(2):175-82. PubMed ID: 15488960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism.
    Coutinho AM; Oliveira G; Morgadinho T; Fesel C; Macedo TR; Bento C; Marques C; Ataíde A; Miguel T; Borges L; Vicente AM
    Mol Psychiatry; 2004 Mar; 9(3):264-71. PubMed ID: 15094787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The current status of association studies in obsessive-compulsive disorder.
    Hemmings SM; Stein DJ
    Psychiatr Clin North Am; 2006 Jun; 29(2):411-44. PubMed ID: 16650716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of serotonin transporter gene polymorphism in tinnitus.
    Deniz M; Bayazit YA; Celenk F; Karabulut H; Yilmaz A; Gunduz B; Saridogan C; Dagli M; Erdal E; Menevse A
    Otol Neurotol; 2010 Jan; 31(1):19-24. PubMed ID: 19924014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of serotonin transporter promoter gene polymorphism (5-HTTLPR) with depression in Costa Rican schizophrenic patients.
    Contreras J; Hernández S; Quezada P; Dassori A; Walss-Bass C; Escamilla M; Raventos H
    J Neurogenet; 2010 Jul; 24(2):83-9. PubMed ID: 20397838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transmission disequilibrium studies in children and adolescents with obsessive-compulsive disorders pertaining to polymorphisms of genes of the serotonergic pathway.
    Walitza S; Wewetzer C; Gerlach M; Klampfl K; Geller F; Barth N; Hahn F; Herpertz-Dahlmann B; Gössler M; Fleischhaker C; Schulz E; Hebebrand J; Warnke A; Hinney A
    J Neural Transm (Vienna); 2004 Jul; 111(7):817-25. PubMed ID: 15206000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation of obsessive-compulsive-, panic-, obsessive-compulsive personality-, and non-disordered individuals by variation in the promoter region of the serotonin transporter gene.
    Perez M; Brown JS; Vrshek-Schallhorn S; Johnson F; Joiner TE
    J Anxiety Disord; 2006; 20(6):794-806. PubMed ID: 16303282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between obsessive-compulsive disorder and a variable number of tandem repeats polymorphism in intron 2 of the serotonin transporter gene.
    Baca-Garcia E; Vaquero-Lorenzo C; Diaz-Hernandez M; Rodriguez-Salgado B; Dolengevich-Segal H; Arrojo-Romero M; Botillo-Martin C; Ceverino A; Piqueras JF; Perez-Rodriguez MM; Saiz-Ruiz J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):416-20. PubMed ID: 17174018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of life stress, 5-HTTLPR genotype, and SLC6A4 methylation on gene expression and stress response in healthy Caucasian males.
    Duman EA; Canli T
    Biol Mood Anxiety Disord; 2015; 5():2. PubMed ID: 25995833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The S/S Genotype of the 5-HTTLPR (Serotonin-Transporter-Linked Promoter Region) Variant of the SLC6A4 Gene Decreases the Risk of Pre-Eclampsia.
    Ramírez-Armas RM; Garza-Veloz I; Olivas-Chávez JC; Covarrubias-Carrillo RM; Martínez-Vázquez MC; Monárrez-Espino J; Ayala-Haro AE; Serrano-Amaya CV; Delgado-Enciso I; Rodriguez-Sanchez IP; Martinez-Fierro ML
    J Pers Med; 2023 Oct; 13(11):. PubMed ID: 38003850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-HT3 receptor influences the washing phenotype and visual organization in obsessive-compulsive disorder supporting 5-HT3 receptor antagonists as novel treatment option.
    Lennertz L; Wagner M; Grabe HJ; Franke PE; Guttenthaler V; Rampacher F; Schulze-Rauschenbach S; Vogeley A; Benninghoff J; Ruhrmann S; Pukrop R; Klosterkötter J; Falkai P; Maier W; Mössner R
    Eur Neuropsychopharmacol; 2014 Jan; 24(1):86-94. PubMed ID: 23928294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-HTTLPR Genotype-Specific Phenotype in Children and Adolescents With Autism.
    Brune CW; Kim SJ; Salt J; Leventhal BL; Lord C; Cook EH
    Am J Psychiatry; 2006 Dec; 163(12):2148-56. PubMed ID: 17151167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.